Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier (Q28235057)

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

The tight junction: a multifunctional complex

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Production and Activation of Matrix Metalloproteinase-2 in Proliferative Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Dynamic behavior of paired claudin strands within apposing plasma membranes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

A new principle for tight junction modulation based on occludin peptides

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Functional overlap between two classes of matrix-degrading proteases in wound healing

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Matrix metalloproteinase expression in human retinal microvascular cells.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Vascular targets of redox signalling in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryos

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

Molecular mechanisms of vascular permeability in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700251

7 January 2021

10.1038/LABINVEST.3700251

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1538009

1030085876

0 references

1538009

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference